Beijing Centergate Technologies (000931.SZ) has a total of 34 products in production selected for the national medical insurance catalog.

Announcement from Zhongguancun (000931.SZ): The company's wholly-owned subsidiary Beijing Zhongguancun Sihuan Pharmaceutical Development Co., Ltd. (Sihuan Pharmaceutical) and its controlling subsidiary Beijing Huasu Pharmaceutical Co., Ltd. (Beijing Huasu) and its wholly-owned subsidiary Shandong Huasu Pharmaceutical Co., Ltd. (Shandong Huasu), as well as Sihuan Pharmaceutical's controlling subsidiary Duoduo Pharmaceutical Co., Ltd. (Duoduo Pharmaceutical), have had some of their drugs selected for the "National Basic Medical Insurance, Maternity Insurance, and Work Injury Insurance Drug List (2025)". A total of 34 products produced by the company were selected for the "Medical Insurance List 2025".